TELA Bio TELA
NASDAQ TELA
$0.86 -0.05 (-5.30%)
As of: Sep 10, 2026 · 3:50 PM EDT

TELA Bio (TELA) EBT Margin (2018 - 2026)

TELA Bio (TELA) posted EBT Margin of 58.07% for Q2 2026, up 9.38% on a QoQ basis from 64.08% in Q1 2026, and down 910.0% year-over-year from 7.17% in Q2 2025.

Analysis

TELA Bio (TELA) EBT Margin (2018 - 2026) Analysis & Trends

TELA Bio has reported EBT Margin for 9 years, with the latest figure at 58.07% in Q2 2026.

  • On a quarterly basis, EBT Margin fell 910.0% year-over-year to 58.07% in Q2 2026; TTM through Jun 2026 was 51.9%, a 312.0% increase from a year earlier, with the FY2025 full-year figure at 48.78%, up 692.0% from the prior year.
  • EBT Margin was 58.07% for Q2 2026 at TELA Bio, up from 64.08% in the prior quarter.
  • The five-year high for EBT Margin was 34.1% in Q1 2024, with the low at 130.66% in Q1 2022.
  • Average EBT Margin over 5 years is 72.65%, with a median of 70.29% recorded in 2026.
  • The sharpest annual moves came in 2024 and 2025: EBT Margin soared 7087 bps in 2024, then plunged 2644 bps in 2025.
  • Over 5 years, EBT Margin stood at 91.32% in 2022, then grew by 12 bps to 80.14% in 2023, then rose by 30 bps to 56.47% in 2024, then advanced by 20 bps to 45.29% in 2025, then retreated by 28 bps to 58.07% in 2026.
  • The last three EBT Margin figures came in at 58.07% (Q2 2026), 64.08% (Q1 2026), and 45.29% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 179.71 Bn 174.10 Bn 7.27 Bn 12.10%
2 Intuitive Surgical 128.01 Bn 122.80 Bn 1.96 Bn 36.46%
3 Medtronic 117.20 Bn 108.38 Bn 6.34 Bn 18.13%
4 Stryker 104.00 Bn 100.53 Bn 4.50 Bn 23.74%
5 Boston Scientific 63.32 Bn 62.78 Bn 3.85 Bn 19.48%
6 Edwards Lifesciences 49.95 Bn 45.70 Bn 1.35 Bn 29.86%
7 Alcon 32.88 Bn 31.43 Bn 1.68 Bn -1.65%
8 Dexcom 32.27 Bn 30.33 Bn 830.00 Mn 24.27%
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 18.32%
10 TELA Bio 49.95 Mn 19.53 Mn 13.94 Mn -58.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -58.07%
Mar 31, 2026 -64.08%
Dec 31, 2025 -45.29%
Sep 30, 2025 -41.58%
Jun 30, 2025 -48.97%
Mar 31, 2025 -60.54%
Dec 31, 2024 -56.47%
Sep 30, 2024 -54.71%
Jun 30, 2024 -78.30%
Mar 31, 2024 -34.10%
Dec 31, 2023 -80.14%
Sep 30, 2023 -76.50%
Jun 30, 2023 -80.45%
Mar 31, 2023 -104.96%
Dec 31, 2022 -91.32%
Sep 30, 2022 -94.26%
Jun 30, 2022 -107.35%
Mar 31, 2022 -130.66%
Dec 31, 2021 -102.41%
Sep 30, 2021 -106.34%